MediSave for the Chronic Disease Management Programme (CDMP)
8 October 2026
Professionals
Allied Health Professionals
Doctors
Nurses
Pharmacists
Guide to MediSave usage for chronic disease management.
The Chronic Disease Management Programme (CDMP) was first introduced in 2006 to help patients with chronic conditions to reduce out-of-pocket expenses for outpatient management of their conditions and help to promote health-seeking behaviours. Eligible patients can utilise their MediSave at MediSave-accredited healthcare entities (all polyclinics, all public hospitals’ specialist outpatient clinics, accredited specialist clinics, and accredited GP clinics) and subsidies at CHAS GP clinics for their chronic conditions.
These conditions often lead to more serious complications if detected late or not followed up regularly. Individuals are therefore encouraged to have a regular family doctor, undergo the recommended health screenings and have regular reviews of their chronic condition, timely medical treatment and lifestyle changes.
The CDMP currently covers a total of 25 chronic conditions:
Diabetes Mellitus / Pre-diabetes
Hypertension
Hyperlipidemia (Lipid Disorders)
Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Chronic Kidney Disease (Nephritis / Nephrosis)
Schizophrenia
Major Depression
Bipolar Disorder
Anxiety
Stroke
Dementia
Osteoarthritis
Parkinson's Disease
Benign Prostatic Hyperplasia
Epilepsy
Osteoporosis
Psoriasis
Rheumatoid Arthritis
Ischaemic Heart Disease
Allergic Rhinitis
Gout
Chronic Hepatitis B
Hyperthyroidism (with effect from 1 Jan 2027)
Hypothyroidism (with effect from 1 Jan 2027)
From 1 January 2027, the MediSave 500/700 will be renamed to the MediSave Chronic and Preventive Care. The withdrawal limits will be increased from $500/$700 to $700/$1,000. Patients who have received treatment within a calendar year for either two or more different CDMP conditions, or for at least one CDMP condition with recognised complications, will be eligible to use up to $1,000.
Clinics interested to participate in CDMP
The CDMP Handbook for Healthcare Professionals (“CDMP Handbook”) is regularly updated to serve as a quick guide on CDMP and cover a range of practice issues from administrative and claims-related matters to broad guidelines on recommended care components of clinical care.
The key changes to the latest CDMP Handbook 2027 will take effect from 1 January 2027. Key changes to the CDMP Handbook 2027 are as follows:
a) Updates on two new CDMP conditions: Inclusion of new chapters on Hyperthyroidism (Chapter Three, page 85) and Hypothyroidism (Chapter Three, page 93);
b) Updates on recommended care components for existing CDMP conditions: Monitoring of individuals with hypertension (HTN) for Diabetes Mellitus (DM) (Chapter Three, page 34), and monitoring of individuals with Lipid Disorders for DM, HTN and weight/height (Chapter Three, page 37);
c) Updates on the minimum age criterion for screening mammograms: Alignment of the CDMP handbook with the latest Screening Test Review Committee (STRC) 2026 guidelines (Chapter Five, page 104)
d) Updates on the Mental Health GP Partnership Programme (MHGPP): Alignment of the CDMP handbook with the latest onboarding criteria for MHGPP (Chapter Two, page 6, and Chapter Three, page 15);
e) Clarification on the CDMP coverage for existing conditions Osteoporosis and Stroke: The CDMP handbook has been updated to provide greater clarity for the CDMP coverage of osteopenia and transient ischaemic attack (TIA) under osteoporosis and stroke respectively.
You may download a copy of the latest CDMP Handbook below.
Clinics that wish to participate in the CDMP can refer to the latest CDMP Handbook (Chapter Two: Registration and MediSave Use) for information on how to become accredited for MediSave to make MediSave claims for patients.
Doctors who wish to be MediSave-accredited and participate in the CDMP can apply at MOH Financing Schemes Accreditation E-service (opens in new tab).